Back to Search
Start Over
Current opinion in ophthalmology
- Source :
- Current Opinion in Ophthalmology. 30:117-124
- Publication Year :
- 2019
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2019.
-
Abstract
- Adherence to chronic use of topical intraocular pressure (IOP) lowering medications is a fundamental barrier to successful, long-term control in patients suffering from glaucoma. This has fueled innovation to create new vehicles for drug administration, new drug formulations with enhanced bioavailability, and minimally invasive glaucoma surgeries (MIGS) with improved risk-benefit profiles to enhance sustained IOP control. The present article is an overview of novel devices in the pipeline.Several new devices that promise to deliver sustained drug therapy and reduce dependence on daily patient adherence are currently being vetted through clinical trials. In addition, the pipeline for new MIGS devices that target sustained IOP control continues to grow.Alternative drug delivery approaches and novel MIGS devices broaden the treatment options for patients with glaucoma. This will allow the clinician to customize treatment by selecting specific approaches based on each patient's individual needs and coexisting ocular pathologies. Additional comprehensive, large-scale, clinical studies will help define the role that these options hold in a constantly evolving treatment paradigm.
- Subjects :
- Intraocular pressure
genetic structures
medicine.medical_treatment
Glaucoma
Drug formulations
Tonometry, Ocular
03 medical and health sciences
Drug Delivery Systems
0302 clinical medicine
Glaucoma surgery
Humans
Minimally Invasive Surgical Procedures
Medicine
In patient
Intraocular Pressure
business.industry
Drug administration
General Medicine
medicine.disease
eye diseases
Ophthalmology
Pharmaceutical Preparations
030221 ophthalmology & optometry
Optometry
sense organs
business
030217 neurology & neurosurgery
Subjects
Details
- ISSN :
- 10408738
- Volume :
- 30
- Database :
- OpenAIRE
- Journal :
- Current Opinion in Ophthalmology
- Accession number :
- edsair.doi.dedup.....0488ead41ebd488f103e8eb857d98c08